Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Dietary essential fatty acids improved skin and hair conditions and partially corrected fat composition in diabetic mice.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Young adults with hair loss face higher risk of stiff arteries.

Testosterone helps human pancreatic cells increase insulin release.

Recognizing and treating early signs of insulin resistance can help prevent type 2 diabetes and improve life quality.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Relatives of women with PCOS symptoms are more likely to have similar health issues.

Exercise and finasteride together improve ovary health in PCOS rats.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Men with severe early-onset baldness may have worse heart artery function and stiffer arteries if they have high blood pressure.